Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Arbuthnot

Showing results (21-30 of 101) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral VectorNjabulo Mnyandu, Patrick Arbuthnot, Mohube Betty Maepa
Expert Opinion on Biological Therapy|December 22, 2017
How successful has targeted RNA interference for hepatic fibrosis been?Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Expert Opinion on Drug Delivery|November 16, 2010
Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activatorsMohube Betty Mowa, Carol Crowther, Patrick Arbuthnot
Current Gene Therapy|April 10, 2009
Hepatic delivery of RNA interference activators for therapeutic applicationPatrick Arbuthnot, Abdullah Ely, Marc S Weinberg
Infection|January 22, 2026
Structural mimics of SARS-CoV-2Natasha Killassy, Patrick Arbuthnot, Mohube Betty Maepa
Anticancer Research|August 15, 2002
Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cellsLuigi Zampieri, Pepita Bianchi, Paul Ruff, et al.
Virology Journal|November 17, 2012
Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cellsVictoria A Green, Patrick Arbuthnot, Marc S Weinberg
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2010
Effective Pol III-expressed long hairpin RNAs targeted to multiple unique sites of HIV-1Sheena M Saayman, Patrick Arbuthnot, Marc S Weinberg
World Journal of Gastroenterology|June 24, 2021
Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approachPrashika Singh, Dylan Kairuz, Patrick Arbuthnot, et al.
Gene Therapy|October 23, 2020
Self-amplifying RNA vaccines for infectious diseasesKristie Bloom, Fiona van den Berg, Patrick Arbuthnot
Pageof 11

Showing results (21-30 of 101) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2020
In Vivo Delivery of Cassettes Encoding Anti-HBV Primary MicroRNAs Using an Ancestral Adeno-Associated Viral VectorNjabulo Mnyandu, Patrick Arbuthnot, Mohube Betty Maepa
Expert Opinion on Biological Therapy|December 22, 2017
How successful has targeted RNA interference for hepatic fibrosis been?Mohube Betty Maepa, Abdullah Ely, Patrick Arbuthnot
Expert Opinion on Drug Delivery|November 16, 2010
Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activatorsMohube Betty Mowa, Carol Crowther, Patrick Arbuthnot
Current Gene Therapy|April 10, 2009
Hepatic delivery of RNA interference activators for therapeutic applicationPatrick Arbuthnot, Abdullah Ely, Marc S Weinberg
Infection|January 22, 2026
Structural mimics of SARS-CoV-2Natasha Killassy, Patrick Arbuthnot, Mohube Betty Maepa
Anticancer Research|August 15, 2002
Differential modulation by estradiol of P-glycoprotein drug resistance protein expression in cultured MCF7 and T47D breast cancer cellsLuigi Zampieri, Pepita Bianchi, Paul Ruff, et al.
Virology Journal|November 17, 2012
Impact of sustained RNAi-mediated suppression of cellular cofactor Tat-SF1 on HIV-1 replication in CD4+ T cellsVictoria A Green, Patrick Arbuthnot, Marc S Weinberg
Methods in Molecular Biology (Clifton, N.J.)|April 14, 2010
Effective Pol III-expressed long hairpin RNAs targeted to multiple unique sites of HIV-1Sheena M Saayman, Patrick Arbuthnot, Marc S Weinberg
World Journal of Gastroenterology|June 24, 2021
Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approachPrashika Singh, Dylan Kairuz, Patrick Arbuthnot, et al.
Gene Therapy|October 23, 2020
Self-amplifying RNA vaccines for infectious diseasesKristie Bloom, Fiona van den Berg, Patrick Arbuthnot
Pageof 11